Newcomb Richard A, Johnson P Connor, Yang Daniel, Holmbeck Katherine, Choe Joanna, Nabily Anisa, Lark Porsha, Dhawale Tejaswini, Amonoo Hermioni L, El-Jawahri Areej
Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Oncologist. 2024 May 3;29(5):441-449. doi: 10.1093/oncolo/oyad295.
Indolent non-Hodgkin's lymphomas (iNHL) are a heterogenous group of mostly incurable diseases with prolonged illness courses and prognostic uncertainty. Yet, studies evaluating coping and perception of prognosis are limited.
We conducted a cross-sectional study of adults newly diagnosed with iNHL in the past 3 months at a single academic center. We assessed quality of life (QOL: Functional Assessment of Cancer Therapy-General), psychological symptoms (Hospital Anxiety and Depression Scale), coping (Brief-COPE), and perception of prognosis (Prognosis Awareness Impact Scale).
We enrolled 70.6% (48/68) of eligible patients. Patients had older age (mean = 66.9,sd = 10.5), were female (60.4%), predominantly identified as White (85.4%), and had at least received a college degree (75%). Chronic lymphocytic leukemia (39.6%) and follicular lymphoma (33.3%) were the most common diagnoses. Overall, 27.1% and 14.6% of patients reported clinically significant anxiety and PTSD symptoms, respectively. Patients highly utilized acceptance (56.2%), seeking emotional support (47.9%), and denial (47.9%) as coping strategies at diagnosis. While 66.7% of patients recalled their oncologist assessment of illness as incurable, only 35.4% reported that the illness is unlikely to be cured. Overall, 45.8% indicated that they were worried about prognosis and 31.2% reported perseverating on their prognosis. Higher emotional coping with prognosis was associated with fewer anxiety (B = -0.6, SE = 0.2, P < .001), depression (B = -0.3, SE = .1, P = .005), and PTSD (B = -1.3, SE = 0.4, P < .001) symptoms and better QOL (B = 1.7, SE = 0.4, P < .001).
Patients with iNHL report substantial psychological distress, a diversity of coping strategies, and complex cognitive understanding of their prognosis. Interventions, which address prognostic uncertainty and promote positive emotional coping with prognosis, may ameliorate psychological distress in this population.
惰性非霍奇金淋巴瘤(iNHL)是一组异质性疾病,大多无法治愈,病程迁延,预后难以确定。然而,评估应对方式和预后认知的研究有限。
我们在一个学术中心对过去3个月内新诊断为iNHL的成年人进行了一项横断面研究。我们评估了生活质量(QOL:癌症治疗功能评估通用版)、心理症状(医院焦虑抑郁量表)、应对方式(简易应对方式问卷)和预后认知(预后认知影响量表)。
我们纳入了70.6%(48/68)符合条件的患者。患者年龄较大(平均=66.9,标准差=10.5),女性占60.4%,主要为白人(85.4%),至少拥有大学学历(75%)。慢性淋巴细胞白血病(39.6%)和滤泡性淋巴瘤(33.3%)是最常见的诊断。总体而言,分别有27.1%和14.6%的患者报告有临床显著的焦虑和创伤后应激障碍症状。患者在诊断时高度采用接受(56.2%)、寻求情感支持(47.9%)和否认(47.9%)作为应对策略。虽然66.7%的患者回忆起肿瘤学家将其病情评估为无法治愈,但只有35.4%的患者报告病情不太可能治愈。总体而言,45.8%的患者表示担心预后,31.2%的患者报告反复思考自己的预后。对预后有更高的情绪应对与较少的焦虑(B=-0.6,标准误=0.2,P<.001)、抑郁(B=-0.3,标准误=0.1,P=.005)和创伤后应激障碍(B=-1.3,标准误=0.4,P<.001)症状以及更好的生活质量(B=1.7,标准误=0.4,P<.001)相关。
iNHL患者报告有严重的心理困扰、多种应对策略以及对预后的复杂认知理解。解决预后不确定性并促进对预后的积极情绪应对的干预措施,可能会改善该人群的心理困扰。